Plastic and reconstructive surgery. Global open · 2026
Effectiveness of Tranexamic Acid in Postbariatric Surgery Abdominoplasty: Improving Hemostasis and Recovery Outcomes.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ciccarelli Feliciano, Moccia Felice, Vastarella Maria Giovanna, Amoroso Arturo, Vastarella Claudia, Vastarella Vincenzo, Pieretti Gorizio
Аннотация
BACKGROUND: Postbariatric abdominoplasty carries an increased risk of perioperative bleeding due to extensive dissection and tissue fragility. Tranexamic acid (TXA) effectively reduces blood loss in several surgical fields, but evidence in postbariatric body-contouring surgery remains limited.
METHODS: A single-center, retrospective pilot study of 200 postbariatric abdominoplasty patients was conducted. One hundred patients received perioperative TXA (intravenous and local), and 100 historical controls did not. Outcomes measured included hemoglobin drop, 24-hour drain output, complications, and hospital stay.
RESULTS: TXA use significantly reduced hemoglobin drop (1.6 ± 0.5 versus 3.1 ± 0.7 g/dL; P < 0.001), drain output (82 versus 154 mL; P < 0.01), and hospital stay (3.0 ± 0.4 versus 4.3 ± 0.6 d; P < 0.001). No thromboembolic events occurred.
CONCLUSIONS: TXA is associated with reduced blood loss and shorter hospitalization in postbariatric abdominoplasty, without increased thromboembolic risk. TXA should be considered as part of perioperative management for this population.
METHODS: A single-center, retrospective pilot study of 200 postbariatric abdominoplasty patients was conducted. One hundred patients received perioperative TXA (intravenous and local), and 100 historical controls did not. Outcomes measured included hemoglobin drop, 24-hour drain output, complications, and hospital stay.
RESULTS: TXA use significantly reduced hemoglobin drop (1.6 ± 0.5 versus 3.1 ± 0.7 g/dL; P < 0.001), drain output (82 versus 154 mL; P < 0.01), and hospital stay (3.0 ± 0.4 versus 4.3 ± 0.6 d; P < 0.001). No thromboembolic events occurred.
CONCLUSIONS: TXA is associated with reduced blood loss and shorter hospitalization in postbariatric abdominoplasty, without increased thromboembolic risk. TXA should be considered as part of perioperative management for this population.